Xenon Pharmaceuticals (NASDAQ:XENE) Cut to “Sell” at StockNews.com
StockNews.com downgraded shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) from a hold rating to a sell rating in a report released on Friday morning. XENE has been the topic of several other reports. Deutsche Bank Aktiengesellschaft started coverage on shares of Xenon Pharmaceuticals in a research report on Tuesday, February 11th. They set a […]
StockNews.com downgraded shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) from a hold rating to a sell rating in a report released on Friday morning. XENE has been the topic of several other reports. Deutsche Bank Aktiengesellschaft started coverage on shares of Xenon Pharmaceuticals in a research report on Tuesday, February 11th. They set a […]
